Skip to main content
. 2022 Nov 21;129(2):283–295. doi: 10.1002/cncr.34507

FIGURE 3.

FIGURE 3

The overall incidence of grade ≥3 treatment‐related adverse events in ADC regimens. ADC indicates antibody–drug conjugate.